ANTI-MICROBIAL ANCILLARIES

SKIN

ASEPSIS

Novapharm has developed a series of the world’s leading skin asepsis product ranges, including Microshield, Avagard and Asepti.

HARD SURFACE CLEANING& DISINFECTION

Novapharm predicted that the ubiquitous incidence of antibiotic resistance would lead away from the use of “neutral detergents” on environmental surfaces towards hard surface disinfectants.

ENZYMATIC

INSTRUMENT

REPROCESSING

Novapharm's range includes (multi) enzymatic detergents for ultrasonic bath, manual & automated reprocessing procedures and washers.

ABOUT US

WHO WE ARE

Since 1986 Novapharm Research has become a world leading Research & Development Company based in Sydney Australia involved in the development of infection prevention & control systems as well as technologies across the critical infection prevention vectors of Hand & Skin Asepsis, Hard Surface disinfection & cleaning, enzymatic instrument cleaning & reprocessing, instrument disinfection and Environmental Hygiene.

Novapharm has powerful, original platform technologies in all of the above infection prevention vectors offering, end-to-end infection control platforms.

COMPANY HISTORY

Since 1986 we have had a proven track record as the source of market leading IP in global Infection Prevention to companies such as J&J, Ecolab, Getinge, Shülke Mayr & 3M. We have developed very strong relationships with critical key global raw material manufacturers that enables early access to new leading ingredients and technologies. The company is ISO 13485 accredited.

OUR PHILOSOPHY

Healthcare professionals throughout the world recognise that the in-vitro efficacy of microbial control solutions has little meaning outside the validating context of the laboratory. To this end, Novapharm’s philosophy toward the development of leading infection prevention products and technologies is driven by an outcome based focus in terms of ‘accountable care’, accreditation and patient safety which delivers effective, innovative and comprehensive solutions based on real world work-flow results.